Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Cash Flow PerformanceFair Value
Percentile Rank57
Studio
Year-over-Year Change

Free cash flow yield

Latest
-25.26%
↑ 22% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive growthFair Value
Average
-32.24%
Historical baseline
PeriodValueYoY Change
2025-25.26%+76.5%
2024-107.66%-150.9%
2023-42.90%-41.5%
2022-30.32%-109.3%
2021-14.49%-868.0%
2020-1.50%+52.0%
2019-3.12%+90.5%
2018-32.65%-